MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (
NASDAQ: MLTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Contact Levi & Korsinsky by December 15, 2025 Deadline to Join Class Action Against MoonLake Immunotherapeutics (MLTX)Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Contact Levi & Korsinsky by December 15, 2025 Deadline to Join Class Action Against MoonLake Immunotherapeutics (MLTX)NEW YORK - November 11, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in MoonLake Immunotherapeutics (
NASDAQ: MLTX) of a class action securities lawsuit.
Lost Money on MoonLake Immunotherapeutics (MLTX)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskySearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Lost Money on MoonLake Immunotherapeutics (MLTX)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyNEW YORK - November 10, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in MoonLake Immunotherapeutics (
NASDAQ: MLTX) of a class action securities lawsuit.
MLTX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that MoonLake Investors Have Opportunity to Lead Class Action LawsuitFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In MoonLake To Contact Him Directly To Discuss Their Options
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (
NASDAQ: MLTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Levi & Korsinsky Reminds MoonLake Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 15, 2025 - MLTXSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Levi & Korsinsky Reminds MoonLake Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 15, 2025 - MLTXNEW YORK - November 7, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in MoonLake Immunotherapeutics (
NASDAQ: MLTX) of a class action securities lawsuit.
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at MoonLake Immunotherapeutics
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Reuters Research Inc. (“MoonLake” or the “Company”) (
NASDAQ: MLTX).
Shareholders That Lost Money on MoonLake Immunotherapeutics (MLTX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Shareholders That Lost Money on MoonLake Immunotherapeutics (MLTX) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreNEW YORK - November 6, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in MoonLake Immunotherapeutics (
NASDAQ: MLTX) of a class action securities lawsuit.
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX)NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (
NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, inclusive.
Bragar Eagel & Squire, P.C. Reminds Investors of aTyr, Marex, Cepton, and MoonLake to Contact the Firm About their Rights in Filed Class Action LawsuitsNEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of aTyr Pharma, Inc. (
NASDAQ:ATYR), Marex Group PLC (
NASDAQ:MRX), Cepton, Inc. (
NASDAQ:CPTN), and MoonLake Immunotherapeutics (
NASDAQ:MLTX). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
Class Action Filed Against MoonLake Immunotherapeutics (MLTX) - December 15, 2025 Deadline to Join - Contact Levi & KorsinskySearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Class Action Filed Against MoonLake Immunotherapeutics (MLTX) - December 15, 2025 Deadline to Join - Contact Levi & KorsinskyNEW YORK - November 4, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in MoonLake Immunotherapeutics (
NASDAQ: MLTX) of a class action securities lawsuit.
MLTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake ImmunotherapeuticsFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $10,000 In MoonLake To Contact Him Directly To Discuss Their Options
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (
NASDAQ: MLTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming DeadlineNEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (
NASDAQ: MLTX) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company.
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (
NASDAQ: MLTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Levi & Korsinsky Reminds MoonLake Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 15, 2025 - MLTXSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
